Kronos Bio Inc.

0.97
0.01 (0.78%)
At close: Feb 28, 2025, 3:59 PM
0.98
1.24%
After-hours: Feb 28, 2025, 04:00 PM EST

Kronos Bio Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 6.29M n/a n/a n/a n/a n/a
Cost of Revenue n/a 4.46M 4.08M 4.87M 605K 160K
Gross Profit 6.29M -4.46M -4.08M -4.87M -605K -160K
Operating Income -121.83M -137.12M -151.4M -58.04M -16.82M -6.64M
Interest Income 9.16M 3.91M 320K 898K 699K n/a
Pretax Income -112.67M -133.2M -151.08M -88.44M -16.12M -6.72M
Net Income -112.67M -129.29M -149.1M -64.09M -15.42M -6.72M
Selling & General & Admin 41.74M 43.4M 38.49M 14.79M 3.37M 1.61M
Research & Development 86.38M 93.72M 112.9M 43.25M 13.45M 5.03M
Other Expenses n/a n/a n/a -27.41M n/a n/a
Operating Expenses 128.12M 137.12M 151.4M 58.04M 16.82M 6.64M
Interest Expense n/a n/a n/a 3.89M n/a 76K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 128.12M 137.12M 151.4M 58.04M 16.82M 6.64M
Income Tax n/a -3.91M -1.98M -24.36M -699K -70.14K
Shares Outstanding (Basic) 57.74M 56.2M 54.75M 54.07M 53.04M 28.45M
Shares Outstanding (Diluted) 57.74M 56.2M 54.75M 54.07M 53.04M 28.45M
EPS (Basic) -1.95 -2.3 -2.72 -1.19 -0.29 -0.24
EPS (Diluted) -1.95 -2.3 -2.72 -1.19 -0.29 -0.24
EBITDA -119.69M -128.74M -147M -79.69M -15.51M -6.49M
Depreciation & Amortization 2.14M 4.46M 4.08M 4.87M 605K 160K